Scotiabank raised the firm’s price target on WM (WM) to $265 from $260 and keeps an Outperform rating on the shares. The firm remains positive on the stock, coming away from the company’s investor day more positive on the Healthcare segment, the analyst tells investors. Scotiabank expects WM to continue raising the dividend at a “strong pace” and resume buybacks when the leverage ratio normalizes.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WM:
- WM price target raised to $250 from $244 at CIBC
- WM price target raised to $245 from $241 at BMO Capital
- WM price target raised to $255 from $251 at Oppenheimer
- Waste Management: Balancing Growth Potential with Near-Term Challenges
- Waste Management: Balancing Promising Growth with Market Uncertainties